Nectar Lifesciences Limited (NECLIFE.BO)
INR 44.02
(0.0%)
INR 44.02
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.97 Billion INR | 75.82% |
| 2022 | 1.92 Billion INR | -35.78% |
| 2021 | 2.99 Billion INR | 16.21% |
| 2020 | 2.57 Billion INR | -30.16% |
| 2019 | 3.68 Billion INR | -10.49% |
| 2018 | 4.12 Billion INR | 12.83% |
| 2017 | 3.65 Billion INR | 0.94% |
| 2016 | 3.61 Billion INR | -3.58% |
| 2015 | 3.75 Billion INR | -2.83% |
| 2014 | 3.86 Billion INR | 0.35% |
| 2013 | 3.84 Billion INR | -1.06% |
| 2012 | 3.88 Billion INR | 19.19% |
| 2011 | 3.26 Billion INR | 13.43% |
| 2010 | 2.87 Billion INR | 7.95% |
| 2009 | 2.66 Billion INR | -66.15% |
| 2008 | 7.87 Billion INR | 2.92% |
| 2007 | 7.64 Billion INR | 58.51% |
| 2006 | 4.82 Billion INR | 62.33% |
| 2005 | 2.97 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 825.1 Million INR | -12.97% |
| 2023 Q2 | 1.1 Billion INR | -4.16% |
| 2023 FY | 3.38 Billion INR | 75.82% |
| 2023 Q1 | 1.14 Billion INR | 253.54% |
| 2023 Q4 | 948.07 Million INR | -24.03% |
| 2023 Q3 | 1.24 Billion INR | 13.28% |
| 2022 Q4 | -748.66 Million INR | -201.57% |
| 2022 FY | 1.92 Billion INR | -35.78% |
| 2022 Q1 | 1.13 Billion INR | 675.29% |
| 2022 Q2 | 799.94 Million INR | -29.46% |
| 2022 Q3 | 737.13 Million INR | -7.85% |
| 2021 Q4 | -197.13 Million INR | -116.71% |
| 2021 FY | 2.99 Billion INR | 16.21% |
| 2021 Q3 | 1.17 Billion INR | 17.41% |
| 2021 Q2 | 1 Billion INR | -0.17% |
| 2021 Q1 | 1 Billion INR | 556.16% |
| 2020 Q4 | -220.6 Million INR | -122.28% |
| 2020 Q1 | 833.82 Million INR | 765.73% |
| 2020 Q3 | 990.17 Million INR | 1.84% |
| 2020 Q2 | 972.3 Million INR | 16.61% |
| 2020 FY | 2.57 Billion INR | -30.16% |
| 2019 Q1 | 1.32 Billion INR | 9035.14% |
| 2019 Q3 | 1.25 Billion INR | 2.13% |
| 2019 FY | 3.68 Billion INR | -10.49% |
| 2019 Q4 | -125.24 Million INR | -109.95% |
| 2019 Q2 | 1.23 Billion INR | -6.82% |
| 2018 Q3 | 1.44 Billion INR | 5.11% |
| 2018 Q1 | 1.28 Billion INR | 0.0% |
| 2018 Q4 | 14.47 Million INR | -99.0% |
| 2018 FY | 4.12 Billion INR | 12.83% |
| 2018 Q2 | 1.37 Billion INR | 7.15% |
| 2017 FY | 3.65 Billion INR | 0.94% |
| 2016 FY | 3.61 Billion INR | -3.58% |
| 2015 Q3 | - INR | 0.0% |
| 2015 FY | 3.75 Billion INR | -2.83% |
| 2014 FY | 3.86 Billion INR | 0.35% |
| 2014 Q3 | - INR | 0.0% |
| 2013 FY | 3.84 Billion INR | -1.06% |
| 2012 FY | 3.88 Billion INR | 19.19% |
| 2011 FY | 3.26 Billion INR | 13.43% |
| 2010 FY | 2.87 Billion INR | 7.95% |
| 2009 FY | 2.66 Billion INR | -66.15% |
| 2008 FY | 7.87 Billion INR | 2.92% |
| 2007 FY | 7.64 Billion INR | 58.51% |
| 2006 FY | 4.82 Billion INR | 62.33% |
| 2005 FY | 2.97 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Ajanta Pharma Limited | 21.06 Billion INR | 85.89% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | -90.941% |
| Sigachi Industries Limited | 2 Billion INR | -48.434% |
| Bal Pharma Limited | 770.19 Million INR | -285.884% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | 52.02% |
| Medico Remedies Limited | 262.14 Million INR | -1033.751% |
| Lasa Supergenerics Limited | 121.02 Million INR | -2355.639% |
| Venus Remedies Limited | 2.18 Billion INR | -36.172% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 593.365% |
| Alpa Laboratories Limited | 188.89 Million INR | -1473.393% |
| Shilpa Medicare Limited | 3.54 Billion INR | 16.206% |
| Aarti Drugs Limited | 8.31 Billion INR | 64.262% |
| Lupin Limited | 123.71 Billion INR | 97.598% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 98.079% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 97.626% |
| Windlas Biotech Limited | 1.33 Billion INR | -121.994% |
| Suven Life Sciences Limited | -200.79 Million INR | 1580.132% |
| Eris Lifesciences Limited | 10.42 Billion INR | 71.496% |
| Valiant Laboratories Limited | -60.66 Million INR | 4999.215% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | 86.907% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -245.107% |
| Ipca Laboratories Limited | 29.8 Billion INR | 90.03% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 19.575% |
| Achyut Healthcare Limited | 4.86 Million INR | -61040.918% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 98.85% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -101.933% |
| RPG Life Sciences Limited | 2.48 Billion INR | -19.696% |
| Mankind Pharma Limited | 44.52 Billion INR | 93.324% |
| Laurus Labs Limited | 24.62 Billion INR | 87.928% |
| Piramal Pharma Limited | 24.47 Billion INR | 87.855% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -215.372% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 93.644% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 88.902% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 95.714% |
| Unichem Laboratories Limited | 4.86 Billion INR | 38.908% |
| Sequent Scientific Limited | 2.97 Billion INR | 0.224% |
| Novartis India Limited | 1.32 Billion INR | -123.985% |
| Wanbury Limited | 1.73 Billion INR | -71.732% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 27.92% |
| Wockhardt Limited | 16.24 Billion INR | 81.699% |
| Themis Medicare Limited | 1.5 Billion INR | -97.623% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -355.425% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 84.87% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 76.095% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 98.183% |
| Divi's Laboratories Limited | 32.44 Billion INR | 90.838% |
| NATCO Pharma Limited | 25.73 Billion INR | 88.452% |
| Gufic Biosciences Limited | 4.16 Billion INR | 28.688% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | 35.119% |
| Ind-Swift Limited | 2.17 Billion INR | -36.802% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 48.593% |
| FDC Limited | 8.33 Billion INR | 64.341% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -1442.109% |
| Granules India Limited | 16.79 Billion INR | 82.308% |
| Medicamen Biotech Limited | 495.49 Million INR | -499.816% |
| Alkem Laboratories Limited | 52.29 Billion INR | 94.317% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 52.238% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -20284.919% |
| Brooks Laboratories Limited | 65.62 Million INR | -4429.198% |
| Megasoft Limited | 342.07 Million INR | -768.843% |
| ZIM Laboratories Limited | 1.26 Billion INR | -134.596% |
| Strides Pharma Science Limited | 14.38 Billion INR | 79.344% |
| Neuland Laboratories Limited | 8.24 Billion INR | 63.966% |
| Morepen Laboratories Limited | 6.16 Billion INR | 51.762% |
| Hikal Limited | 3.14 Billion INR | 5.441% |
| Indoco Remedies Limited | 6.04 Billion INR | 50.804% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 49.033% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -378.996% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -322.405% |
| Hester Biosciences Limited | 1.27 Billion INR | -133.35% |